Source: Virtual Congress 2020 – New investigations of bronchiectasis and non-tuberculous mycobacteria
Disease area: Airway diseases, Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
M. Loebinger (London, United Kingdom), S. Aliberti (Milan, Italy), R. Menendez (Valencia, Spain), F. Blasi (Milan, Italy), P. Burgel (Paris, France), F. Ringshausen (Hannover, Germany), M. Trautmann (Barcelona, Spain), A. Davis (Barcelona, Spain), A. De Soyza (Newcastle, United Kingdom), M. Shteinberg (Haifa, Israel), A. Shoemark (Dundee, United Kingdom), J. Altenburg (Amsterdam, Netherlands), J. Chalmers (Dundee, United Kingdom), M. Vendrell (Girona, Spain), E. Polverino (Barcelona, Spain), S. Skrgat (Golnik, Slovenia), M. Van Der Eerden (Rotterdam, Netherlands), W. Boersma (Alkmaar, Netherlands), O. Sibila (Barcelona, Spain), M. Mcdonnell (Galway, Ireland), L. Maiz (Madrid , Spain), P. Kauppi (Helsinki, Finland), V. Botnaru (Chisinau, Republic of Moldova), E. Van Braeckel (Gent, Belgium), N. Lorent (Leuven, Belgium), J. Rademacher (Hannover, Germany), C. Haworth (Cambridge, United Kingdom), K. Dimakou (Athens, Greece), A. Torres (Barcelona, Spain), T. Welte (Hannover, Germany), S. Elborn (Belfast, United Kingdom), P. Goeminne (Belgium, Belgium). Alpha-1 antitrypsin deficiency in patients with bronchiectasis: data from the European Bronchiectasis Registry EMBARC. 3330

Member's Comments

No comment yet.

Related content which might interest you: The national alpha-1 antitrypsin deficiency registry in Poland Source: International Congress 2015 – Chronic airway disorders: miscellaneous aspects Year: 2015 Bronchiectasis but not emphysema is more prevalent in non-PiZ alpha-1 antitrypsin deficiency (AATD) COPD than in usual COPD Source: International Congress 2014 – Genetics and environmental factors underlying asthma and COPD Year: 2014 Alpha-1 antitrypsin deficiency in patients with COPD/emphysema, bronchiectasis and asthma Source: Virtual Congress 2020 – New biomarkers for management of obstructive diseases Year: 2020 COPD and alpha-1 antitrypsin deficiency emphysema: characteristics and survival after Lung Transplantation Source: International Congress 2018 – Moving lung transplantation forward Year: 2018 Association between alpha 1 antitrypsin and bronchiectasis Source: International Congress 2015 – Management of asthma and other respiratory diseases in primary care Year: 2015 The impact of diagnostic delay on survival in alpha-1-antitrypsin deficiency - results from the Austrian Alpha-1 Lung Registry Source: Virtual Congress 2021 – What's new in respiratory problems in rare and systemic diseases Year: 2021 Population pharmacokinetics of A1-PI in patients with Alpha-1 antitrypsin deficiency Source: International Congress 2015 – New data on established treatments for COPD Year: 2015 Alpha-1 antitrypsin deficiency and lung cancer: Description of a cohort of patients in northwestern Spain Source: Virtual Congress 2021 – Screening, diagnosis, management and prognosis of lung cancer Year: 2021 Characteristics of zz alpha-1 antitrypsin deficiency patients on the Irish national registry Source: Annual Congress 2012 - Inflammation in airway diseases: diagnosis and management Year: 2012 Asthma as a co-morbidity and cause of bronchiectasis: data from the European Bronchiectasis Registry (EMBARC). Source: Virtual Congress 2020 – Non-tuberculous mycobacterial infections and bronchiectasis Year: 2020 Screening for alpha-1 antitrypsin deficiency in Polish lung or liver disease patients Source: Annual Congress 2011 - Lung development and neoplasia Year: 2011 Long-term evolution of individuals with alpha1 antitrypsin deficiency from the Spanish registry Source: International Congress 2015 – New frontiers in the management of interstitial and orphan lung diseases Year: 2015 Alpha-1 antitrypsin deficiency in COPD patients: Time to count it in! Source: Virtual Congress 2020 – Pharmacological management of COPD Year: 2020 ATS / ERS: Standards for the Diagnosis and Management of Individuals with Alpha-1 Antitrypsin Deficiency Source: Guideline 2003 Year: 2003 Pulmonary rehabilitation (PR) in patients with COPD due to alpha-1 antitrypsin deficiency (AATD): 15 years experience at the Maugeri Institute Source: Annual Congress 2013 –The best posters in pulmonary rehabilitation Year: 2013 Immunodeficiency associated bronchiectasis in the European Bronchiectasis Registry (EMBARC) Source: Virtual Congress 2020 – New insight into the pathogenesis of chronic lung diseases: asthma, COPD and others Year: 2020 Bronchiectasis in patients with alpha1-antitrypsin deficiency: prevalence and characteristics Source: International Congress 2016 – Imaging of COPD and airways: structural and functional assessments Year: 2016 Differences of disease phenotypes in individuals with alpha-1-antitrypsin deficiency with genotypes PiZZ and PiSZ - Analysis from the German registry Source: International Congress 2016 – Phenotyping and monitoring airway diseases Year: 2016 The Irish national alpha-1 antitrypsin deficiency targeted detection programme Source: Annual Congress 2013 –Epidemiology of respiratory disease Year: 2013